SMS Pharmaceuticals Board of Directors
Get the latest insights into the leadership at SMS Pharmaceuticals. Learn about the experienced professionals guiding the company's strategy and governance.
| Name | Position |
|---|---|
| Mr. Ramesh Babu Potluri | Chairman & Managing Director |
| Mr. Vamsi Krishna Potluri | Executive Director |
| Mr. Sarath Kumar Pakalapati | Independent Director |
| Mr. Sharvan Kudaravalli | Independent Director |
| Mr. Sarvepalli Srinivas | Independent Director |
| Dr.(Mrs.) Neelaveni Thummala | Independent Director |
SMS Pharmaceuticals Share price
SMSPHARMA
233.17
0.66 (-0.28%)NSE
BSE
Last updated on 4 Sep, 2025 | 15:51 IST
BUYSELL
Today's High
239.00
Today's Low
232.50
52 Week Low
176.05
52 Week High
398.00
The current prices are delayed, login to your account for live prices
LoginSMS Pharmaceuticals FAQs
The board at SMS Pharmaceuticals consists of experienced professionals, including Mr. Ramesh Babu Potluri , Mr. Vamsi Krishna Potluri , and others, overseeing the company’s strategic and corporate governance.
Directors at SMS Pharmaceuticals are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.
As of the latest update, Mr. Ramesh Babu Potluri is the current chairman at SMS Pharmaceuticals.
Executive directors at SMS Pharmaceuticals are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.
Yes, SMS Pharmaceuticals adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.
At SMS Pharmaceuticals, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.